IBEX (IBEX) awards 4,400 RSUs to Chief Legal Officer in Form 4

Rhea-AI Filing Summary

IBEX Ltd reported an equity award to its Chief Legal Officer, Christina Alice Trofimuk-O'Connor. She acquired 4,400 common shares in the form of restricted stock units (RSUs) at a price of $0.0000 per share, bringing her direct holdings to 35,735 common shares.

The RSUs vest over four years: 25% on July 1, 2026, with 25% vesting each year for the following three years, contingent on continued service. On each vesting date, IBEX will automatically withhold shares to cover tax obligations in a non-discretionary transaction.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Trofimuk-O'Connor Christina Alice

Role Chief Legal Officer

Type	Security	Shares	Price	Value
Grant/Award	Common Shares	4,400	$0.00	--

Holdings After Transaction: Common Shares — 35,735 shares (Direct)

Footnotes (1)

1. [object Object]

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Trofimuk-O'Connor Christina Alice

(Last) (First) (Middle)

C/O IBEX LIMITED

1717 PENNSYLVANIA AVENUE NW, SUITE 825

(Street)

WASHINGTON DC 20006

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
IBEX Ltd [ IBEX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Legal Officer

3. Date of Earliest Transaction (Month/Day/Year)
02/26/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Shares	02/26/2026		A		4,400(1)	A	$0(1)	35,735	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. 25% of the RSUs vest on July 1, 2026, with 25% of the RSUs vesting annually thereafter for the following three years, provided that the Reporting Person remains in continuous service on each vesting date. Unless otherwise provided, on each vesting date shares of Common Stock will automatically be withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations in a non-discretionary transaction.

Remarks:

	Lisa Lenstrohm, Attorney-in-Fact	02/27/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did IBEX (IBEX) report in this Form 4?

IBEX reported that Chief Legal Officer Christina Alice Trofimuk-O'Connor received 4,400 restricted stock units, representing common shares. The award was recorded at a price of $0.0000 per share and is structured to vest over a multi-year period, subject to continued service conditions.

How many IBEX (IBEX) shares does the insider hold after this grant?

After the RSU grant, the reporting officer is shown holding 35,735 IBEX common shares directly. This total reflects the new award added to her prior holdings, as disclosed in the Form 4 non-derivative transaction table for the reported date.

What are the vesting terms of the IBEX (IBEX) restricted stock units?

The RSUs vest 25% on July 1, 2026, with an additional 25% vesting on each of the next three annual anniversaries. Vesting requires the reporting person to remain in continuous service with IBEX on each scheduled vesting date under the award’s terms.

How does IBEX (IBEX) handle taxes on the RSU vesting for this award?

On each vesting date, IBEX will automatically withhold shares of common stock to satisfy the insider’s tax withholding obligations. The footnote describes this as a non-discretionary transaction, meaning the withholding occurs automatically under the award’s terms.

What transaction code is used in the IBEX (IBEX) Form 4 and what does it mean?

The Form 4 uses transaction code “A,” described as a grant, award, or other acquisition. In this context, it reflects the officer’s acquisition of 4,400 restricted stock units, which each represent a contingent right to receive one share of IBEX common stock upon vesting.

Are the IBEX (IBEX) RSUs immediately settled in common shares?

The RSUs are not immediately settled; they represent a contingent right to receive one common share per unit. Settlement occurs as the units vest over four years, assuming the officer continues service through each vesting date specified in the grant terms.